https://www.selleckchem.com/pr....oducts/ferrostatin-1
Transcatheter aortic valve replacement (TAVR) has developed into an established therapy for patients with severe aortic stenosis (AS) across the spectrum of surgical risk. Despite improvements in transcatheter heart valve (THV) technologies and procedural techniques, cardiac conduction disturbances, including high degree atrioventricular block (AV requiring permanent pacemaker (PPM) implantation and new-onset left bundle branch block (LBB, remain frequent complications. TAVR-related conduction disturbances occur due to injury
Like
Comment
Share
